On January 13, 2018, Merck Pharmaceuticals, Yili Capsules and Qianjin Pharmaceuticals held the 2017 Annual Working Conference in Yili Capsules Conference Room. More than 40 middle-level cadres and outstanding staff representatives attended the meeting, which was chaired by Vice President Liang Feng of Meike Pharmaceutical Industry.

     At the meeting, the heads of Meike, Qianjin and Yili departments summarized the work in 2017, reviewed the achievements, analyzed the existing problems and deficiencies, and worked out the specific work ideas and plans for the next step of the Department combined with the strategic development direction of the company in 2018. The principal person in charge of Qianjin and Yili made a speech on fulfilling the work target of 2018, and put forward concrete measures for fulfilling the target task.

       In order to clarify the objectives and strengthen responsibility, Jinjin Pharmaceutical Co., Ltd. and Yili Capsule Co., Ltd. and the sales department signed the target assessment responsibility letters for 2018 respectively. Finally, Zhu Junwei, the chairman of the board of directors of the company, made an important speech. On the basis of affirming the efforts made in 2017, he hoped that all of us would come up with the spirit of "meeting the brave in a narrow way and winning in a narrow way". We should always keep in mind the "six consciousness" - crisis consciousness, responsibility consciousness, competition consciousness, quality consciousness, cost consciousness and transformation. Consciousness. Confidence, and strive to achieve "contradictions do not hand in, quality does not happen, service does not vacancy, implementation to be in place", to ensure that the meeting to determine the completion of the task objectives, but also for the realization of the IPO listing in 2020 lay the foundation for the grand blueprint.